Stimulants Mimic A Night Of Sound Sleep Rather Than Directly Boost Attention In A Nutshell Not attention networks: ADHD ...
Omeros to Host Conference Call Monday, December 29, 2025 at 4:30 p.m. ET -- -- First and only approved option: YARTEMLEA(R) is the only approved treatment for hematopoietic stem cell ...
Policymakers across Europe and the United States are moving to classify many clinical AI tools as high-risk systems, ...
Pretax loss widens to GBP6.2 million from GBP3.1 million. ProService says trading conditions remain challenging, with a weak commercial environment impacting performance. It now expects full-year ...
With José Antonio Kast’s victory, Pinochetism returns to power through electoral means, articulating neoliberal restoration, moral authoritarianism, and anti-communism as a response to Chile’s crisis.
Omeros Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved YARTEMLEA® (narsoplimab-wuug) for the treatment of hematopoietic stem cell transplant-associated ...
Boston-based Beth Israel Deaconess Medical Center played a role in a new FDA decision that allows bone mineral density, measured through noninvasive imaging, to serve as a qualified endpoint in ...
Discover how drugs prevent, cure, and alleviate ailments. Learn about over-the-counter vs. prescription drugs and the ...
ME/CFS is a neurological condition characterized by malaise. Diagnosis requires ruling out other systemic illnesses.
Discover how credit card validation codes work and protect against fraud. Learn about their placement, security role, and examples to secure online transactions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback